Mindbloom

Psychedelic medicine is here

Headquarters: New York, New York
Employees: 201–500
Founded: 2018
Business Model: B2C

Website: mindbloom.com
Total Funding: $2.0M
Last Round: $2.0M SeedJan 2021

About

Mindbloom is the largest national provider of at-home ketamine therapy for depression, anxiety, and PTSD. Founded in 2018, the company combines clinician-prescribed medicine with 1:1 coaching, group integration circles, and live support. Over 10,000 clients have participated in peer-reviewed clinical studies, with 89% reporting improvement in symptoms.

LinkedIn X (Twitter)

Tech Stack

Frontend

Webflow

Other

Intercom

App Stack

Sign up to view funding chart

Create a free account to see funding visualizations and detailed round data.

Create Free Account

Funding History

Sign up to view funding details

Create a free account to see full funding history, valuations, and investor participation.

Create Free Account

Investors

Sign up to view investors

Create a free account to see which investors have funded this company.

Create Free Account